Table 1.
Factors | MA.5 | MA.12 | MA.14 | MA.21 | MA.27 | HERA |
---|---|---|---|---|---|---|
Total N | 710 | 672 | 665 | 2083 | 7571 | 3028 |
Age < 50 | 84% | 82% | 3% | 61% | 3% | 51% |
Menopausal status: Pre/uncertain | 100% | 100% | 0% | 68% | 0% | 54% |
Race White | n/a | n/a | 97% | 89% | 95% | 83% |
ECOG performance 0 | 81% | 65% | 78% | 84% | 82% | 91% |
Node positive | 100% | 75% | 47% | 72% | 28% | 64% |
T1/in situ | 37% | 43% | 58% | 35% | 72% | 35% |
Hormone receptor positive | 68% | 75% | 91% | 61% | 100% | 51% |
Chemotherapy | 100% | 100% | 31% | 100% | 31% | 100% |
Anthracyclines | 49% | 55% | 25% | 100% | 28% | 93% |